Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amy J Davidoff

Showing results (71-80 of 120) with videos related to

Pageof 12
Sort By:
Medical Care|February 14, 2018
Changes in Health Insurance Coverage Associated With the Affordable Care Act Among Adults With and Without a Cancer History: Population-based National EstimatesAmy J Davidoff, Gery P Guy, Xin Hu, et al.
Journal of Oncology Practice|January 8, 2015
Patient cost sharing and receipt of erythropoiesis-stimulating agents through medicare part DAmy J Davidoff, Franklin B Hendrick, Amer M Zeidan, et al.
Journal of Geriatric Oncology|June 26, 2018
Functional trajectories before and after a new cancer diagnosis among community-dwelling older adultsC J Presley, Ling Han, Linda Leo-Summers, et al.
Haematologica|January 3, 2012
Patient and physician characteristics associated with erythropoiesis-stimulating agent use in patients with myelodysplastic syndromesAmy J Davidoff, Sheila Weiss Smith, Maria R Baer, et al.
The American Journal of Managed Care|July 27, 2021
ACA Medicaid expansion association with racial disparity reductions in timely cancer treatmentBlythe J S Adamson, Aaron B Cohen, Cary P Gross, et al.
Therapeutic Advances in Hematology|February 14, 2022
Contemporary practice patterns of tyrosine kinase inhibitor use among older patients with chronic myeloid leukemia in the United StatesRory M Shallis, Rong Wang, Jan P Bewersdorf, et al.
Journal of Comparative Effectiveness Research|March 14, 2018
Development and validation of a claims-based approach to proxy ECOG performance status across ten tumor groupsKristin M Sheffield, Lee Bowman, David M Smith, et al.
Journal of Molecular and Cellular Cardiology|December 11, 2012
In vivo and in vitro cardiac responses to beta-adrenergic stimulation in volume-overload heart failureAnuradha Guggilam, Kirk R Hutchinson, T Aaron West, et al.
Cancer|December 11, 2012
Out-of-pocket health care expenditure burden for Medicare beneficiaries with cancerAmy J Davidoff, Mujde Erten, Thomas Shaffer, et al.
Leukemia Research|April 15, 2015
Variations in erythropoiesis-stimulating agent administration in transfusion-dependent myelodysplastic syndromes impact responseVu H Duong, Maria R Baer, Franklin Hendrick, et al.
Pageof 12

Showing results (71-80 of 120) with videos related to

Sort By:
Pageof 12
Medical Care|February 14, 2018
Changes in Health Insurance Coverage Associated With the Affordable Care Act Among Adults With and Without a Cancer History: Population-based National EstimatesAmy J Davidoff, Gery P Guy, Xin Hu, et al.
Journal of Oncology Practice|January 8, 2015
Patient cost sharing and receipt of erythropoiesis-stimulating agents through medicare part DAmy J Davidoff, Franklin B Hendrick, Amer M Zeidan, et al.
Journal of Geriatric Oncology|June 26, 2018
Functional trajectories before and after a new cancer diagnosis among community-dwelling older adultsC J Presley, Ling Han, Linda Leo-Summers, et al.
Haematologica|January 3, 2012
Patient and physician characteristics associated with erythropoiesis-stimulating agent use in patients with myelodysplastic syndromesAmy J Davidoff, Sheila Weiss Smith, Maria R Baer, et al.
The American Journal of Managed Care|July 27, 2021
ACA Medicaid expansion association with racial disparity reductions in timely cancer treatmentBlythe J S Adamson, Aaron B Cohen, Cary P Gross, et al.
Therapeutic Advances in Hematology|February 14, 2022
Contemporary practice patterns of tyrosine kinase inhibitor use among older patients with chronic myeloid leukemia in the United StatesRory M Shallis, Rong Wang, Jan P Bewersdorf, et al.
Journal of Comparative Effectiveness Research|March 14, 2018
Development and validation of a claims-based approach to proxy ECOG performance status across ten tumor groupsKristin M Sheffield, Lee Bowman, David M Smith, et al.
Journal of Molecular and Cellular Cardiology|December 11, 2012
In vivo and in vitro cardiac responses to beta-adrenergic stimulation in volume-overload heart failureAnuradha Guggilam, Kirk R Hutchinson, T Aaron West, et al.
Cancer|December 11, 2012
Out-of-pocket health care expenditure burden for Medicare beneficiaries with cancerAmy J Davidoff, Mujde Erten, Thomas Shaffer, et al.
Leukemia Research|April 15, 2015
Variations in erythropoiesis-stimulating agent administration in transfusion-dependent myelodysplastic syndromes impact responseVu H Duong, Maria R Baer, Franklin Hendrick, et al.
Pageof 12